Ligand validation:3ZY5

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZY5_BTB_A_1387	55%	55%	0.138	0.905	0.55	1.16	-	1	0	0	100%	1
3ZY4_BTB_A_1385	11%	32%	0.188	0.732	0.54	2.12	-	5	1	0	86%	0.8571
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1
2OQL_BTB_B_701	95%	63%	0.066	0.969	0.66	0.75	-	-	0	0	100%	1
4WQM_BTB_A_406	94%	34%	0.068	0.966	1.71	0.91	3	-	1	0	100%	1
5O5D_BTB_B_504	94%	66%	0.071	0.969	0.94	0.38	2	-	0	0	100%	1
4AYO_BTB_A_503	92%	53%	0.085	0.977	1.02	0.8	1	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.